Cargando…
Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs
BACKGROUND: Radiotherapy is routinely used to combat glioblastoma (GBM). However, the treatment efficacy is often limited by the radioresistance of GBM cells. METHODS: Two GBM lines MO59K and MO59J, differing in intrinsic radiosensitivity and mutational status of DNA-PK and ATM, were analyzed regard...
Autores principales: | Djuzenova, Cholpon S., Fischer, Thomas, Katzer, Astrid, Sisario, Dmitri, Korsa, Tessa, Steussloff, Gudrun, Sukhorukov, Vladimir L., Flentje, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582108/ https://www.ncbi.nlm.nih.gov/pubmed/34763650 http://dx.doi.org/10.1186/s12885-021-08930-1 |
Ejemplares similares
-
Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule
por: Djuzenova, Cholpon S., et al.
Publicado: (2016) -
MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule
por: Grabenbauer, Felix, et al.
Publicado: (2018) -
FocAn: automated 3D analysis of DNA repair foci in image stacks acquired by confocal fluorescence microscopy
por: Memmel, Simon, et al.
Publicado: (2020) -
Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities
por: Memmel, Simon, et al.
Publicado: (2017) -
Contraction of the rigor actomyosin complex drives bulk hemoglobin expulsion from hemolyzing erythrocytes
por: Shirakashi, Ryo, et al.
Publicado: (2022)